Sleep Apnea Diagnostic System Market, By Product Type (Polysomnography (PSG) Devices (Ambulatory PSG Monitoring Devices, Clinical PSG Monitoring Devices), Sleep Apnea Screening Devices (Nasal Flow Sensors, Peripheral Capillary Oxygen Saturation (SPO2), Actigraphy Monitoring Devices)), By End User (Home Care Settings, Hospitals, Sleep Centers and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023

Code : CMI3435

Pages :175

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Global Sleep Apnea Diagnostic System Market – Driver

Increasing product launches by the key market players

It is projected that the market would expand as a result of key market players are introducing new products to meet the increased demand for innovative products. As an illustration, to cover the gap created by the Philips CPAP recall, ResMed, medical device company, announced new sleep apnea equipment in August 2021. In a similar vein, GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea, introduced O2Vent Optima in February 2021. This product is a highly effective and portable substitute for CPAP therapy.

Global Sleep Apnea Diagnostic System Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global sleep apnea diagnostic system market. For instance, patients with obstructive sleep apnea (OSA) had a 2.93 times greater risk of hospitalization when afflicted by COVID-19 than non-OSA persons, according to research published in the British Medical Journal (BMJ) Open Respiratory Research in January 2021.